Navigation Links
Panmira and FLAP LLCs Spun Out of Amira Pharmaceuticals
Date:9/8/2011

SAN DIEGO, Sept. 8, 2011 /PRNewswire/ -- Panmira Pharmaceuticals, LLC and FLAP, LLC, today announced their formation around certain assets spun out immediately preceding the acquisition of Amira Pharmaceuticals, Inc. (Amira) by Bristol-Myers Squibb Company (NYSE: BMY).  Panmira Pharmaceuticals received a number of assets, including Amira's DP2 antagonists, AM211 and AM461, both of which have successfully completed Phase I clinical studies.  FLAP, LLC is a non-operating company with rights to future milestones and royalties from Amira's 2008 licensing deal with GlaxoSmithKline related to the 5-lipoxygenase-activating protein (FLAP) inhibitor program.

"Now that we have successfully completed the sale of Amira to Bristol-Myers Squibb Company, a subset of the former Amira team will focus on completing our partnership efforts for the DP2 program," said Bob Baltera, Chief Executive Officer of Panmira Pharmaceuticals.  "We believe that spinning out these assets will be the best way to maximize their value for Amira's shareholders, and we look forward to accomplishing this goal."

Hari Kumar, Ph.D., Chief Business Officer, added, "Clinical trial results have demonstrated a dose proportional pharmacodynamic (PD) effect and good safety profiles for both AM211 and AM461.  These compounds are primed and ready for Phase II exploration in a number of clinical settings, including asthma, chronic obstructive pulmonary disease (COPD) and eosinophillic esophagitis.  We look forward to having the right partner to help make these plans come to fruition."

While there are no DP2 selective antagonists approved for therapeutic use, there is a strong scientific rationale for the target to be a novel, potentially disease-modifying treatment of asthma, COPD and allergic rhinitis. DP2, also known as chemoattractant receptor-homologous molecule expressed in Th2 lymphocytes (CRTH2), is a high affinity receptor for the prostaglandin D2 and is impli
'/>"/>

SOURCE Panmira Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society
2. Amira Pharmaceuticals Announces Completion of Phase 1 Clinical Study for AM152, A Novel LPA1 Receptor Antagonist
3. Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis
4. Amira Pharmaceuticals Announces the Nomination of an Orally Available Pre-Clinical Candidate in a New LPA-Related Program, an Autotaxin Inhibitor
5. Amira Pharmaceuticals Announces Initiation of Phase I Clinical Trial for AM152, A Novel LPA1 Antagonist
6. Amira Pharmaceuticals Announces IND Submission for Novel LPA1 Antagonist, AM152, for Potential Use in Fibrotic Diseases
7. Amira Pharmaceuticals Named One of Most Promising Biotech Companies by FierceBiotechs Annual Fierce 15
8. Visage Imaging Releases Amira 5.3
9. Amira Announces AM103 and AM803 Patent Grant in the United Kingdom
10. Amira Announces Second DP2 Antagonist Patent Grant in the United Kingdom
11. Anti-Fibrotic Data from Amira Pharmaceuticals LPA1 Receptor Antagonist Program Published in the British Journal of Pharmacology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... -- IRIDEX Corporation (Nasdaq: IRIX ) today reported financial ... 2015.  , Revenues were $11.8 million in the ... up 11% from $10.6 million in the 2013 fourth quarter. ... 12% from $38.3 million in 2013. , Gross margin ... in the fourth quarter of the prior year. , ...
(Date:3/5/2015)... 5, 2015 Bayer HealthCare announced today that ... Cancer Foundation of the American Society of Clinical Oncology ... technology platform designed to unlock vast quantities of information ... "Bayer is proud to join ASCO and ... Big Data to help people whose lives have been ...
(Date:3/5/2015)...   AMC Health , the leading provider ... the effectiveness and efficiency of healthcare for high-risk ... and Jared Wilstead have joined the ... Client Development, and Wilstead will serve as Vice ... commitment to accelerating the adoption of monitored care ...
Breaking Medicine Technology:IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3
... 2010 Mederi Therapeutics Inc announced today that it ... and use of Mederi,s second generation of the Stretta ... of gastric reflux disease, commonly known as GERD, and ... disorder, or BCD.  These latest systems include a streamlined ...
... 8, 2010 DURECT Corporation (Nasdaq: DRRX ... CEO, will be presenting at the Credit Suisse 2010 ... Pacific Time. The conference is being held at the ... ) (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) ...
Cached Medicine Technology:Mederi Therapeutics Announces Receipt of CE Mark for its Second Generation Secca® and Stretta® Systems 2
(Date:3/5/2015)... 05, 2015 Central Nebraska Imaging (CNI) ... including the brand’s new logo and optimized website. ... practice’s modern approach to expert diagnostic imaging, centered on ... be built to be a resource for Nebraska patients ... automated forms, communication and referral functionality, video content and ...
(Date:3/5/2015)... On March 2, 2015, NBC News posted ... Rise, Plastic Surgeons Say,” that comments on the 2014 ... Plastic Surgery and the American Society of ... doubling of surgical butt augmentations performed in 2014. According ... this increase can be attributed to the social impact ...
(Date:3/5/2015)... March 05, 2015 At the ... Beyond,” leaders in addiction treatment met today in Jackson, ... best clinical practices. Among the numerous respected speakers will ... will address the role that pain medications have had ... evidence-based treatment options. , "It is hard to believe ...
(Date:3/5/2015)... 05, 2015 University of Western ... in 1904, has launched a new center of ... changes. The Northwest Center for Lifestyle and Functional ... community outreach, and conduct research in the areas ... and nutrition. The center will target efforts on ...
(Date:3/5/2015)... 2015 Dr. Jonathan Glashow a board ... has been named by Castle Connolly as ... Dr. Glashow has been selected by Castle Connolly Medical ... top specialty care doctors in the tri-state metropolitan New ... program, which carefully screens and selects doctors through a ...
Breaking Medicine News(10 mins):Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2Health News:Dr. Jonathan Glashow, NYC Orthopedic Surgeon, Named Top Doctor: New York Metro Area 2
... leader in end-to-end bill cycle automation, supplies Integrated ... ... Compensation Payers, CONCORD, Calif., Dec. 17 Paradigm ... and complex,medical management services has entered an agreement with ...
... Diagnostic Health Corporation,(DHC) today announced that it ... home office operations to 22 Inverness Center Parkway ... company created,by HealthSouth,s sale of its diagnostic division ... of DHC,s 1,000 employees work in its network ...
... of dying were 50% higher , MONDAY, Dec. 17 (HealthDay ... risk of death, according to a University of Pennsylvania School ... December issue of the Archives of Dermatology . , ... and joints -- has been linked with a number of ...
... People are more pleased with their teeth than professionals might ... People tend to be much happier with the condition of ... report. , Patients also view eyes and teeth as the ... 50 are most at ease with the appearance of their ...
... troubled by,depression usually experience their dark moods in an ... differs only in,that the oscillations follow a seasonal schedule, ... through the spring. Lack of light,is often blamed for ... SAD,sufferers is still in question, reports the January 2008 ...
... Petitions FDA to Require Clearer Warnings on DTC Device,Ads, ... petition with the FDA requesting it require all advertisements ... valve replacements,cosmetic implants and heart stents -- carry a ... the devices once they are in the,body., Implantable ...
Cached Medicine News:Health News:Paradigm Selects Jopari to Provide E-Billing Gateway for Customers 2Health News:Paradigm Selects Jopari to Provide E-Billing Gateway for Customers 3Health News:Diagnostic Health Corporation Announces New Home Office Location 2Health News:Severe Psoriasis Linked to Higher Death Risk 2Health News:Dentists Take Dimmer View of Patients' Smiles 2Health News:Dentists Take Dimmer View of Patients' Smiles 3Health News:Dentists Take Dimmer View of Patients' Smiles 4Health News:Lack of Light and Seasonal Depression - What's the Link? From the Harvard Health Letter 2Health News:Advertisements for Medical Devices, Implants Should Carry Warnings of Dangerous Side Effects, Infections 2
... TANGO is designed for ... services, donor centers and ... testing and antibody screening. ... host of functions including ...
The ScanGel® automatic readings are done with a high resolution color video camera. Images can be stored and printed....
... Since the early 1990s, the "Reversed" shoulder ... surgeons with great success. More recently, an ... States have begun to champion this prosthesis ... with it. This reversed technology is the ...
... SPEX Fluorolog-3, a spectro-fluorometer ... JOBIN YVON), is a new ... tailored combination of various components. ... customers to freely choose components ...
Medicine Products: